|
V-Patch Medical Systems (Pacific) is an Australian-based division of V-Patch Medical Systems plc, a UK registered company. V-Patch Medical Systems (VPMS) in partnership with Sensor Technology and Devices from Belfast Northern Ireland (a spin out company from Ulster University) and Cobalt Niche Industrial Designers in Melbourne, have designed, developed and manufactured a set of miniaturised, wearable, non-invasive and non obtrusive biosensors comprising disposable “patches” and non disposable, wearable, “smart-analysis”, modules with wireless connection to cell phone networks and the internet.
V-Patch Medical Systems commissioned Sensor Technology and Devices (ST&D) in Belfast to fully develop the original concept as ST&D are acknowledged as world experts in biosensors having developed biosensors for SpaceLab on behalf of NASA and the MIR Space Project in recent years. Additioanlly, Ulster University has stood at the forefront of cardiac developments in defibrillation technology for over 30 years
V-Patch addresses an important need in mainstream cardiology. The system builds on the existing global practices of early identification and subsequent treatment of at-risk cardiac patients but does so in a far more cost effective manner utilising established telecommunications infrastructure and capturing all critical patient data as and when cardiac events occur.
Further developments of this platform technology are under way and in time will address a number of chronic disease states that threaten the health of all citizens as well as the ability of governments to fund diagnosis and treatment. These diseases include kidney disease, congestive cardiac failure, diabetes, obesity, hypertension, and Obstructve Airways Disease.
VPMS quality management systems are fully certified to ISO9001:2000, ISO 13485, GMP. The CE Mark has been obtained. TGA approval and FDA clearance with 510(k) approval to market are currently being sought.
VPMS is currently establishing a distribution network through out Western Europe, North America, South America, Asia, India and parts of the Middle East and Africa and welcomes approaches from interested distributors world wide.
The VPMS range is also fundamental to the product offering of other companies especially in the e-health arena and is currently looking at opportunities for OEM arrangements and joint ventures.
VPMS (Pacific) P/L, as part of VPMS plc, has developed miniaturised, non-invasive devices for real time cardiac event surveillance and reporting of patients cardiac events to clinicians whilst both groups are going about daily life without need to be anchored in one spot.
Patient wear slim-line disposable “patches” connected to a small unobtrusive hardware set with built-in intelligence that collects, analyses and transmits to treating physicians, but only those signals of interest, by utilizing existing cell phone networks and the internet.
Breach settings for a series of cardiac events can be altered remotely by the treating physician who will then receive reports and bio-data at any site, at any time, from any place on a variety of devices including laptop or PCs, fax, hand helds or cell phone including SMS.
Physicians can access patient rhythm strips at any time and are alerted to adverse beats. Interventions can be organised remotely with the timely arrival of patients and related medical data on an as-needs basis to a treatment site of choice.
Current biosensors are for diagnostic quality ECG, respiration wave and rhythm in a wide out-of-hospital setting. Phase II will utilise the existing biosensors but in an in-hospital setting.
Competitive Advantages
The V-Patch Sytem is disruptive technology and re-defines the approach cardiologists may now take in managing their patients.
The early identification and management of cardiac risk is highly cost effective as it allows current service providers to fulfil their obligations for a fraction of the cost as well as greatly expand the range of mobility of patients and clinicians as to where, how and when data can be transmitted and reviewed.
Much more sophisticated patient monitoring can be performed allowing earlier diagnosis to occur.
www.vpatchmedical.com
 
|